MENU NEWS & EVENTS What’s new at MannKind. press releases NOVEMBER 9, 2021 MannKind Corporation Reports 2021 Third Quarter Financial Results Conference Call to Begin Today at 5:00 p.m. (ET) 3Q 2021 Total Revenues of $22.2 million ; +45% vs. 3Q 2020 3Q 2021 Afrezza Net Revenue of $9.8 million ; + ... read more NOVEMBER 9, 2021 Mannkind Corporation Closes Sale-Leaseback Transaction Generating $102.25 Million in Non-Dilutive Gross Proceeds WESTLAKE VILLAGE, Calif. and DANBURY, Conn. , Nov. 09, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development ... read more NOVEMBER 5, 2021 MannKind Presents Data at 21st Annual Diabetes Technology Meeting A Technosphere ® Insulin (TI) dose – approximately double the estimated mealtime subcutaneously (SC) injection dose – reduced postprandial glucose excursio ... NOVEMBER 2, 2021 MannKind Corporation to Hold 2021 Third Quarter Financial Results Conference Call on November 9, 2021 WESTLAKE VILLAGE, Calif. , Nov. 02, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2021 third quarter financial results and i ... view all news & events view newsletter Make a humann connection with us. Reach out anytime. MannKind Corporation 30930 Russell Ranch Road, Suite 300 Westlake Village, CA 91362 USA contact@mannkindcorp.com 818.661.5000 sign up for email updates Terms of Use Privacy Policy Patent Notices Corporate Governance ©2021 MannKind Corporation. All rights reserved.